Company profile: Evaluate
1.1 - Company Overview
Company description
- Provider of trusted commercial intelligence for the pharmaceutical and medical device industries, offering EvaluatePharma online subscription services that deliver a standardized view of the global pharmaceutical market's past, present, and future. Offerings include data feeds integrating forecast, trial, and key event data, asset screening, competitive landscape analysis, commercial opportunity assessment, company profiling, and data-driven thought leadership.
Products and services
- Data Feeds: Evaluate delivers system-integrated feeds combining forecast, trial, and key event data to embed commercial intelligence into systems for strategic decision-making
- Competitive Landscape Analysis: Evaluate architects trend-focused tools that analyze market dynamics, trends, and competitors to understand growth drivers and product differentiators for strategic decision-making
- Commercial Opportunity Assessment: Evaluate produces forecast-backed assessments that identify and validate pharmaceutical opportunities by examining market fit, risk, and sales forecasts for robust, strategic decision-making
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Evaluate
Almac
HQ: United Kingdom
Website
- Description: Provider of contract development and manufacturing services to pharmaceutical and biotech companies globally, including R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, and IXRS technology. Offers genomic services, clinical trial assays, companion diagnostics, PD biomarker testing, CDx manufacturing, and the claraT software.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Almac company profile →
Avenacy
HQ: United States
Website
- Description: Provider of critical injectable pharmaceuticals, manufacturing generic and therapeutic equivalents including eptifibatide (generic Integrilin) for acute coronary syndrome, bivalirudin (generic Angiomax), fosaprepitant, fulvestrant in prefilled syringe kits, and desmopressin acetate, offered in sterile single-dose vials, multi-dose vials, and sterile powder formulations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avenacy company profile →
eStudySite
HQ: United States
Website
- Description: Provider of clinical research services delivering study-related care and conducting inpatient and outpatient protocols, including first-in-human, pivotal, and post-marketing studies; specializing in infectious disease trials (antibiotics, antivirals, vaccines, diagnostics). Expertise in endocrinology, hepatology, dermatology, gastroenterology; infusion center; community recruitment; ICH/FDA/GCP-compliant, ACLS/BLS-certified staff.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full eStudySite company profile →
Bioceros
HQ: The Netherlands
Website
- Description: Provider of biopharmaceutical R&D contract services spanning discovery research to pre-clinical development, including assay development and quantification, molecular and cell biology, and services related to preclinical development of monoclonal antibodies and generation of protein-producing cell lines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioceros company profile →
Aenova
HQ: United States
Website
- Description: Provider of pharmaceutical and healthcare services, including development, manufacturing and packaging of pharmaceuticals and dietary supplements across oral solids, semi-solids, liquids, sterile dosage forms, and soft gelatin and vegan soft capsules. Offers formulation, process and analytical development, stability studies, regulatory support, clinical trial management, animal health services, and biologics fill and finish for vials and prefilled syringes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aenova company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Evaluate
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Evaluate
2.2 - Growth funds investing in similar companies to Evaluate
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Evaluate
4.2 - Public trading comparable groups for Evaluate
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →